DISTRIBUTION
CEVA PHYLAXIA EXPANSION
“ Making an industrial and supply chain choice that was consistent with the purpose of the company was extremely important ,” he adds .
On the energy front , Ceva invested in 1,500 square metres of photovoltaic panels for the centre , producing around 50 % of the energy consumed .
Moreover , a series of technological choices have been made to limit energy consumption , especially around temperature control .
Jean-Marcel elaborates : “ On one side is limitation of the consumption and on the other side is the investment in photovoltaic panels , so in the end we achieve that 50 %.
The Ceva Phylaxia site in Monor , Hungary , has long been at the forefront of combatting major livestock diseases through innovative research and vaccine development .
Ceva ’ s € 75m investment is set to establish a new 7,000-square-metre plant where the company will produce fermentation-based multicomponent inactivated vaccines for animals .
“ With the addition of this new production unit in Monor , we aim to create new synergies to advance preventive medicine ,” says Marc Prikazsky , Chairman and CEO at Ceva .
“ This project reflects our commitment to supporting farmers worldwide by developing tailored solutions to tackle emerging diseases and new variants .”
The new plant is scheduled to start operations at the end of 2026 .
supplychaindigital . com 123